Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and pantoprazole

pyrroles has been researched along with pantoprazole in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grimmsmann, T; Himmel, W; Schwabe, U1
Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S1
Fukudo, M; Katsura, T; Kunimatsu, S; Mizuno, T1
Bergamini, MF; Bindewald, EH; de Oliveira, MC; Marcolino, LH; Noronha, BV; Papi, MA1

Other Studies

4 other study(ies) available for pyrroles and pantoprazole

ArticleYear
The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Atorvastatin; Continuity of Patient Care; Databases, Factual; Drug Prescriptions; Drug Utilization Review; Follow-Up Studies; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Outpatients; Pantoprazole; Proton Pump Inhibitors; Pyrroles

2007
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    International journal of clinical pharmacy, 2012, Volume: 34, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pantoprazole; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Pyrroles; Renal Dialysis; Rhabdomyolysis; Risk Factors; Treatment Outcome

2012
Effect of P-glycoprotein and breast cancer resistance protein inhibition on the pharmacokinetics of sunitinib in rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphate; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Brain; Indoles; Male; Pantoprazole; Pyrroles; Rats; Rats, Wistar; Sunitinib; Tissue Distribution

2013
Potentiometric determination of pantoprazole using an ion-selective sensor based on polypyrrole doped films.
    Materials science & engineering. C, Materials for biological applications, 2014, Volume: 43

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Ion-Selective Electrodes; Pantoprazole; Polymerization; Polymers; Potentiometry; Pyrroles

2014